Evolution of HIV disease in the third millennium: clinical and related economic issues

被引：8

作者：

Manfredi, R ^{[1
]}

机构：

[1] Univ Bologna, S Orsola Hosp, Div Infect Dis, Dept Clin & Expt Med, I-40138 Bologna, Italy

来源：

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2002年 / 19卷 / 03期

关键词：

D O I：

10.1016/S0924-8579(01)00494-0

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：251 / 253

页数：3

共 13 条

[1] Progress in hiv therapeutics and the challenges of adherence to antiretroviral therapy [J].

Andrews, L ;

Friedland, G .

INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2000, 14 (04) :901-+

[2] The cost of HIV treatment and care - A global review [J].

Beck, EJ ;

Miners, AH ;

Tolley, K .

PHARMACOECONOMICS, 2001, 19 (01) :13-39

[3] Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy. [J].

Bozzette, SA ;

Joyce, G ;

McCaffrey, DF ;

Leibowitz, AA ;

Morton, SC ;

Berry, SH ;

Rastegar, A ;

Timberlake, D ;

Shapiro, MF ;

Goldman, DP .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (11) :817-823

[4] Economic analysis of initial HIV treatment - Efavirenz- versus indinavir-containing triple therapy [J].

Caro, JJ ;

O'Brien, JA ;

Migliaccio-Walle, K ;

Raggio, G .

PHARMACOECONOMICS, 2001, 19 (01) :95-104

[5] Antiretroviral therapy in adults - Updated recommendations of the International AIDS Society-USA Panel [J].

Carpenter, CCJ ;

Cooper, DA ;

Fischl, MA ;

Gatell, JM ;

Gazzard, BG ;

Hammer, SM ;

Hirsch, MS ;

Jacobsen, DM ;

Katzenstein, DA ;

Montaner, JSG ;

Richman, DD ;

Saag, MS ;

Schechter, M ;

Schooley, RT ;

Vella, S ;

Yeni, PG ;

Volberding, PA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 283 (03) :381-390

[6] Modeling the long-term outcomes and costs of HIV Antiretroviral therapy using HIV RNA levels: Application to a clinical trial [J].

Cook, J ;

Dasbach, E ;

Coplan, P ;

Markson, L ;

Yin, DP ;

Meibohm, A ;

Nguyen, BY ;

Chodakewitz, J ;

Mellors, J .

AIDS RESEARCH AND HUMAN RETROVIRUSES, 1999, 15 (06) :499-508

[7] The cost effectiveness of combination antiretroviral therapy for HIV disease. [J].

Freedberg, KA ;

Losina, E ;

Weinstein, MC ;

Paltiel, AD ;

Cohen, CJ ;

Seage, GR ;

Craven, DE ;

Zhang, H ;

Kimmel, AD ;

Goldie, SJ .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (11) :824-831

[8]

Keiser P, 2001, J ACQ IMMUN DEF SYND, V27, P14, DOI 10.1097/00126334-200105010-00003

[9] Decreased medical expenditures for care of HIV-seropositive patients - The impact of highly active antiretroviral therapy at a US Veterans Affairs Medical Center [J].

Mole, L ;

Ockrim, K ;

Holodniy, M .

PHARMACOECONOMICS, 1999, 16 (03) :307-315

[10] Cost effectiveness of combination HIV therapy - 3 years later [J].

Moore, RD .

PHARMACOECONOMICS, 2000, 17 (04) :325-330

← 1 2 →